Helios BioScience is devoted mainly to developing novel human derived products for cell culture and tissue regeneration. Helios BioScience provides new technologies to translate cell based therapies to the commercialization as well as towards xenogeneic-free manufacturing of mesenchymal stem cell. The transition to clinical trials employing mesenchymal stem cell is evolving rapidly. Helios BioScience has novel product that is an intense interaction between basic and clinical applications to deepen our knowledge and to develop safe but efficacious MSC-based novel therapies.